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Abstract 
Background: Although larviciding can reduce the number of outdoor biting malaria vector mosquitoes, which may 
help to prevent residual malaria transmission, the current larvicide repertoire is faced with great challenges to sustain‑
ability. The identification of new effective, economical, and biorational larvicides could facilitate maintenance and 
expansion of the practice of larviciding in integrated malaria vector mosquito control programmes. Interfering RNA 
molecules represent a novel class of larvicides with untapped potential for sustainable mosquito control. This investi‑
gation tested the hypothesis that short interfering RNA molecules can be used as mosquito larvicides.
Results: A small interfering RNA (siRNA) screen for larval lethal genes identified siRNAs corresponding to the Anoph-
eles gambiae suppressor of actin (Sac1), leukocyte receptor complex member (lrc), and offtrack (otk) genes. Saccharomyces 
cerevisiae (baker’s yeast) was engineered to produce short hairpin RNAs (shRNAs) for silencing of these genes. Feeding 
larvae with the engineered yeasts resulted in silenced target gene expression, a severe loss of neural synapses in the 
larval brain, and high levels of larval mortality. The larvicidal activities of yeast interfering RNA larvicides were retained 
following heat inactivation and drying of the yeast into user‑friendly tablet formulations that induced up to 100% 
larval mortality in laboratory trials.
Conclusions: Ready‑to‑use dried inactivated yeast interfering RNA larvicide tablets may someday be an effective and 
inexpensive addition to malaria mosquito control programmes and a valuable, biorational tool for addressing residual 
malaria transmission.
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Background
Although insecticide-treated nets (ITNs) and indoor 
residual spraying (IRS) have been the backbone for 
malaria vector control, resistance to insecticides used for 
these applications is a growing problem. Furthermore, 
these interventions cannot control mosquitoes that bite 
or rest outdoors [1]. As residual transmission of malaria 
becomes increasingly problematic, there is renewed 
interest in the use of larval source management (LSM) 
for reduction of residual transmission. In the first half of 
the twentieth century, LSM was a large-scale and highly 
effective method for control of malaria. Although large-
scale LSM programmes were disbanded and replaced by 
IRS with dichlorodiphenyltrichloroethane (DDT) in the 
latter part of the century, LSM is still a major compo-
nent of integrated mosquito control programmes in some 
parts of the world [2]. Moreover, LSM, unlike IRS and 
ITNs, can reduce the number of mosquitoes that enter 
houses and the number of outdoor-biting mosquitoes [3].
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Larviciding, a form of LSM, involves the application of 
chemical or biological agents to water bodies for target-
ing of immature aquatic larvae and pupae before they 
become malaria vector mosquitoes. Integrated control 
programmes that included larviciding were successful in 
Tanzania, Sudan, and Mauritius [2, 3], and a recent study 
in Kenya demonstrated that long-lasting FourStar™ bri-
quette larvicides significantly reduced mean densities of 
indoor- and outdoor-biting adult malaria vector mosqui-
toes [4]. The World Health Organization (WHO) recom-
mended that larviciding, when used as a supplement to 
ITNs and IRS in sub-Saharan Africa, is cost-effective for 
malaria control in urban settings where vector breeding 
sites are few, fixed, and findable [2]. However, given the 
increase of reported insecticide resistance and rising con-
cern for the negative effects of pesticides on non-target 
organisms, the current pesticide repertoire is faced with 
great challenges to sustainability [1]. The identification 
of new, environmentally safe, cost-effective larvicides is 
critical if the current levels of larviciding are to be sus-
tained or expanded.
Interfering RNA molecules represent a novel class of 
larvicides with untapped potential for sustainable mos-
quito control. Although RNA interference (RNAi) is 
beginning to attract attention in agricultural biotechnol-
ogy communities [5–7], RNAi is still a largely unexplored 
approach for control of disease vector mosquitoes. The 
RNAi pathway is initiated by Dicer, which cleaves long 
pieces of double stranded RNA (dsRNA) into small inter-
fering RNAs (siRNAs) which silence genes that are com-
plementary in sequence. Most mosquito researchers use 
longer (300–400 bp) dsRNA molecules for RNAi. How-
ever, the short length (21–25 bp) of custom siRNAs and 
their short hairpin RNA (shRNA) counterparts facilitates 
the design of interfering RNA that targets mosquitoes, 
but not humans or other non-target organisms [8, 9]. 
siRNAs have facilitated our functional genetic charac-
terization of mosquito larval development [10–14]. This 
investigation tested the hypothesis that short interfering 
RNA molecules can be utilized as larvicidal agents for 
control of Anopheles mosquitoes. The authors recently 
conducted a high throughput screen (MDS, in prepara-
tion) that resulted in the identification of > 100 mosquito 
siRNA larvicides. Here, the characterization of highly 
toxic interfering RNAs targeting three larval lethal mos-
quito genes identified in the screen, suppressor of actin 
(Sac1), leukocyte receptor complex member (lrc), and 
offtrack (otk), is described. The study then describes the 
bioengineering and testing of a Saccharomyces cerevisiae 
(baker’s yeast) system for delivery of these interfering 
RNA molecules to Anopheles gambiae mosquito larvae. 
The results of this investigation demonstrate that heat-
inactivated dry yeast interfering RNA pellets targeting 
these genes induce severe defects in the mosquito central 
nervous system and up to 100% larval mortality.
Methods
Animal rearing
The A. gambiae M strain (obtained from N. Besansky) and 
the Aedes aegypti Liverpool-IB12 (LVP-IB12; obtained 
from D. Severson) strain were used in these studies and 
maintained generally as described [15], except that an 
artificial membrane feeding system was used for deliv-
ery of sheep blood (HemoStat Laboratories, Dixon, CA) 
to adult female mosquitoes. The insects were reared in 
an insectary maintained at 26 °C, at ~ 80% humidity, and 
under a 12  h light/12  h dark cycle with 1  h crepuscular 
periods at the beginning and end of each light cycle.
Identification of larvicidal siRNAs
An siRNA larvicide screen led to the identification 
of siRNAs Sac1.1 and Sac1.91 which correspond to 
Sac1 (AGAP000891), lrc.2 and lrc.51 which target lrc 
(AGAP008903), and otk.16 and otk.94 which correspond 
to otk (AGAP011489). For the screen, custom siRNAs 
corresponding to Anopheles orthologs of a subset of 
Drosophila larval lethal genes [16] as well as a control 
siRNA [14] with no known target in An. gambiae were 
purchased from Integrated DNA Technologies. The 
sequences targeted by these siRNAs, are as follows:
Sac1.1: 5′CCAACUGCAUCGACUGUCUGGACCG3′
Sac1.91: 5′GCCUAAUCAACCUGAUCGACCACAA3′
lrc.2: 5′AUUGGUUCAUCGAGCGUGAACGCAA3′
lrc.51: 5′CCAGCACCAGCCAACGAGGAACACU3′
otk.16: 5′GCUCGGUACGGUACAGUUUCACUGC3′
otk.94: 5′GGACAAAGAUCUGCAGUAUCUGCAU3′
Control: 5′GAAGAGCACUGAUAGAUGUUAGCGU3′
Basic local alignment search tool (BLAST) [17] searches 
indicated that the siRNAs corresponding to Sac1, lrc, 
and otk lacked identical matches in Aedes mosquitoes, 
amphibians, birds, fish, fungi, humans, mammals, plants, 
and reptiles (Additional file  1). The screen involved a 
dual-testing approach that included microinjection of 
third instar larvae as well as soaking of first instar larvae, 
both of which were performed in duplicate. For injec-
tions, ~ 10 pmol custom screening siRNA were injected 
in a 30 nL volume per larva (n = 30/condition/replicate) 
using previously described methodology [18, 19]. siRNAs 
were simultaneously screened through delivery via lar-
val soaking (per [20]), which permitted a second round 
of selection to identify siRNAs that are capable of killing 
mosquitoes early in larval development following only 
brief exposure to siRNA, which may better simulate field 
conditions. For soaking experiments, 20 first instar lar-
vae/condition/replicate were exposed to 20 µL of 0.5 µg/
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µL siRNA for 4 h. Following siRNA treatment, larvae were 
reared and lethality evaluated per the WHO [21] larvicide 
testing guidelines. The mortality of larvae treated with 
siRNA via soaking or microinjection was compared to 
control-treated animals using the Fisher’s exact test [22]. 
In the larval screen, as well as all other larvicide assays 
reported here, larvae that were not treated with larvicidal 
or control RNA and fed a normal laboratory diet were 
reared in parallel. No significant differences in the mortal-
ity of control-treated vs. non-treated larvae were detected 
in any of the assays conducted in this investigation. The 
results for control-treated larvae are reported herein.
Bacteria interfering RNA larvicide preparation and feeding
Heat-killed non-pathogenic Escherichia coli expressing 
dsRNAs of interest were constructed and fed to larvae 
beginning in the first instar (L1) stage using the general 
protocol of Whyard et  al. [20], which was adapted for 
use in An. gambiae. Strain HT115-DE3, obtained from 
the Caenorhabditis Genetics Center (which is funded 
by the NIH Office of Research Infrastructure Programs, 
P40 OD010440), was used in these studies. Bacteria 
were transformed with the dsRNA transcription plasmid 
pL4440 (deposited at Addgene by Andrew Fire; plasmid 
# 1654), which contains forward and reverse T7 poly-
merase binding sites that flank a multiple cloning site in 
which DNA corresponding to the Sac1.1, lrc.2, or otk.16 
siRNA target sequences had been cloned. This permit-
ted inducible expression of dsRNA in E. coli, which were 
prepared and fed to larvae as discussed [23], with liver 
powder being substituted for ground fish food (Doc-
tors Foster and Smith, Stable Diet, Rhinelander, Wis-
consin). Escherichia coli that had been transformed 
with GFP:L4440, which was deposited at Addgene by 
Guy Caldwell (Addgene plasmid # 11335) and expresses 
dsRNA corresponding to GFP, was used as a control feed-
ing strain in these experiments. Data were compiled from 
at least two biological replicate experiments, each with 
four replicate cups bearing 20 animals for each treatment 
(n = 240 control-treated larvae, 240 lrc.2-treated larvae, 
and 160 otk.16-treated larvae) and assessed by ANOVA 
with Tukey’s multiple comparison test.
Yeast interfering RNA larvicide preparation and feeding
shRNA-encoding DNA oligonucleotides correspond-
ing to the Sar1.1, lrc.51, otk.16, and control siRNA tar-
get sequences were custom synthesized by Invitrogen 
Life Technologies. These shRNA expression cassettes 
were cloned into the non-integrating pRS426 GPD yeast 
shuttle vector, which has a URA3 marker and permits 
constitutive expression of inserts cloned downstream of 
a GPD promoter [24]. Following sequencing to confirm 
the hairpin expression cassette sequences, the plasmids 
were transformed into S. cerevisiae strain BY4742 [25] 
(genotype MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0). 
Transformants were selected by checking for growth 
on minimal media lacking uracil. Following selection, 
the yeast was grown to an  OD600 of 3.0 under standard 
conditions in synthetic media. For gel-coated formula-
tions, the Whyard et al. [23] procedure for bacterial pel-
let preparation was used in conjunction with a 50  mL 
yeast culture. For preparation of dried tablet formula-
tions, 50  mL of yeast culture was transferred to 50  mL 
conical tubes and pelleted by centrifugation for 20  min 
at 4000  rpm (Eppendorf 5810R plus), and the super-
natant (culture media) was discarded. For heat inac-
tivation, the pellet was placed in a 70  °C water bath for 
5 min. The yeast pellet was then placed into a 2 mL tube 
which contained 10 mg of fish food and centrifuged for 
1  min at ~  13.2  rpm (Eppendorf, 5415D). The superna-
tant was discarded, and the open tubes were placed in an 
incubator at 30 °C for 48 h to permit evaporation of the 
remaining media. The dried tablets were stored in capped 
microfuge tubes at – 20 °C. The final weight of each yeast 
tablet averaged 95 mg, including 10 mg of fish food and 
85 mg of yeast (~ 1.6 × 1010 cells).
For each replicate, agarose-gel coated yeast pellets were 
divided into three portions, with each portion fed daily 
to 20 larvae beginning in L1 for 3  days. For dried yeast 
formulations, at the beginning of each experiment, one 
control or experimental tablet was placed in a container 
with 20 L1 animals. The larval bioassays were performed 
in 500 mL plastic cups containing 50 mL of water. For the 
gel-coated live yeast experiments, data were compiled 
from two biological replicate experiments, each with 
three replicates per condition and 20 larvae per replicate 
for a total n of 120 larvae/condition. For the gel-coated 
inactivated yeast experiments, data were compiled from 
three biological replicate experiments, each with three 
replicates per condition and 20 larvae per replicate for a 
total n of 180 larvae/condition. For the dried inactivated 
yeast tablet experiments, data were compiled from three 
biological replicate experiments with four replicates per 
condition and 20 animals per replicate (n = 240 larvae/
condition). Yeast interfering RNA larvicide data were 
assessed by ANOVA with Tukey’s multiple comparison 
test.
Whole mount in situ hybridization 
and immunohistochemistry
Riboprobes corresponding to the Sac1, lrc, and otk genes 
were synthesized according to the Patel [26] protocol, 
and in situ hybridization experiments were performed in 
duplicate according to the Haugen et al. [27] protocol. At 
the initiation of tissue fixation, larvae were living. Stained 
tissues were mounted, analysed, and imaged using a Zeiss 
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Axioimager equipped with a Spot Flex camera. For quan-
tification of transcripts, mean gray values were calcu-
lated for digoxigenin-labeled transcript signal in control 
or experimental brains. For each probe, the results from 
three biological replicate experiments were compiled 
(n = 40 control-treated brains/per probe, n = 85 Sac1.1-
treated brains, n = 80 lrc.51-treated brains, and n = 80 
otk.16-treated brains). A t test was used to analyse tran-
script quantification data.
Immunohistochemical staining experiments were 
performed as described [28, 29] using the nuclear stain 
TO-PRO-3 iodide (Molecular Probes, Eugene, OR) and 
mAb 3C11, which recognizes the Synapsin-1 cleaved 
fragment [30]. mAb 3C11 was deposited by E. Buchner 
at the Developmental Studies Hybridoma Bank, a facil-
ity created by the NICHD of the NIH and maintained 
at The University of Iowa. Larvae were still living at the 
initiation of tissue fixation. Following processing, the tis-
sues were mounted and then imaged at the IUSM Flow 
Cytometry and Imaging Core facility using a Zeiss 710 
confocal microscope and Zen software. FIJI ImageJ and 
Adobe Photoshop CC 2014 software were used to ana-
lyse the images. Three biological replicate experiments 
were performed, with a total of 25 brains evaluated per 
condition.
Results
Sac1, otk and lrc are mosquito larval lethal genes
A dual-screening approach was employed to evaluate 
siRNAs corresponding to Anopheles orthologs of Dros-
ophila melanogaster larval lethal genes [16] for larvicidal 
activity. siRNAs were screened both through microinjec-
tion of third instar larvae (Fig. 1a) as well as through 4 h 
soaking treatment of first instar larvae (Fig. 1b). Micro-
injection of siRNA Sac1.1, which corresponds to the 
Sac1 gene, resulted in 42 ± 4% larval mortality (Fig. 1a; 
p  <  0.01 vs. control siRNA injected animals). siRNA 
lrc.2, which targets a sequence in the lrc gene, resulted 
in significant 42  ±  2% mortality following injection 
(Fig.  1b; p  <  0.05 vs. control), while injection of siRNA 
otk.16, which corresponds to otk, yielded 40  ±  4% lar-
val mortality (p < 0.001 vs. control). siRNAs Sac1.1, lrc.2, 
and otk.16 also displayed significant larvicidal activ-
ity (p < 0.01 vs. control) in short-term exposure soaking 
experiments conducted with first instar larvae, inducing 
45 ± 12, 29 ± 6 and 28 ± 5% larval mortality, respectively 
(Fig.  1b). These experiments indicated that exposure to 
the siRNAs either early (L1) or later (L3) in larval devel-
opment can result in death.
The larvicidal activity of these interfering RNAs was 
further confirmed by feeding larvae heat-killed E. coli 
prepared as described by Whyard et  al. [23] that had 
been engineered to express dsRNA corresponding to the 
Sac1.1, lrc.2, and otk.16 siRNA target sequences. These 
experiments, in which bacteria interfering RNA larvi-
cides Sac1.1, lrc.2, and otk.16 induced 43  ±  1, 99  ±  0, 
and 84  ±  1% death (Fig.  1c), further demonstrated the 
larvicidal capacity of these interfering RNA molecules. 
Silencing experiments were also conducted with siR-
NAs corresponding to additional target sequences in 
the Sac1, lrc, and otk genes. Injection of siRNA Sac1.91, 
which corresponds to an alternative target site in Sac1, 
induced 29  ±  2% larval mortality (p  <  0.05 vs. control 
siRNA). siRNA lrc.51, which targets an alternate site 
in lrc, resulted in 55 ±  1% death (p  <  0.001 vs. control 
siRNA) following soaking treatment. Injection of siRNA 
Fig. 1 Larval mortality is induced by interfering RNA larvicides with target sites in the Sac1, lrc, and otk genes. The Sac1.1, lrc.2, and otk.16 siRNAs 
were identified in a screen for larval lethal genes in which siRNAs were evaluated by microinjection of third instar larvae (a) and through brief soak‑
ing treatment of first instar larvae (b). In the screen, an siRNA with no known target in Anopheles gambiae served as the control (a, b). The screen 
was performed in duplicate (see “Methods” for further details). For each replicate, 30 animals per treatment were microinjected, and 20 animals/
treatment were soaked. Data were analysed with Fisher’s exact test [22]. c The larvicidal activity of these interfering RNAs was further confirmed 
when significant mortality was observed in larvae fed with heat‑inactivated E. coli expressing dsRNA corresponding to the Sac1.1, lrc.2, and otk.16 
target sites. Animals fed with bacteria expressing dsRNA corresponding to GFP served as the control in these experiments. Data were compiled 
from replicate experiments (n = 240 control‑treated larvae, 160 Sac1.1‑treated larvae, 240 lrc.2‑treated larvae, and 160 otk.16‑treated larvae) and 
assessed by two‑way ANOVA with Tukey’s multiple comparison test. ***p < 0.001 in comparison to control‑fed larvae; **p < 0.05 in comparison to 
control‑fed larvae; error bars denote standard errors of the mean (SEMs)
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otk.94, which corresponds to an alternative target site in 
otk, induced 40  ±  10% mortality (p  <  0.001 vs. control 
siRNA). These results indicate that targeting alternative 
sites in Sac1, lrc, or otk induces larval death, providing 
further evidence that these genes are required for larval 
survival.
Exploration of yeast interfering RNA delivery systems
The results from the siRNA larval lethal screen and bacte-
rial short dsRNA larvicide studies supported the hypoth-
esis that yeast expressing shRNA that targets larval lethal 
genes could be used as larvicides. In initial experiments, 
shRNA corresponding to the Sac1.1, otk.16, or control 
siRNA target sequence was constitutively expressed 
from a non-integrating multi-copy yeast shuttle plasmid 
that was transformed into S. cerevisiae. This yeast strain, 
as well as a control yeast strain expressing shRNA with 
no known target in An. gambiae, was initially fed to lar-
vae in an agarose gel-covered formulation (Fig. 2a) using 
methodology that was comparable to the preparation of 
bacterial interfering RNA larvicides. Since both live and 
heat-inactivated bacteria can induce mosquito death 
[23], both live and dead yeast covered in agarose were 
tested. While control-fed larvae survived, gel-coated live 
yeast larvicides Sac1.1 and otk.16 killed 80 ± 4 (Fig. 2a; 
p < 0.001 vs. control) and 83 ± 4% of mosquitoes (Fig. 2a; 
p < 0.001 vs. control), respectively. Heat-inactivated gel-
coated yeast Sac1.1 induced 86 ± 1% mortality (Fig. 2b; 
p  <  0.001 vs. control), while heat-inactivated gel-coated 
yeast otk.16 induced 84 ± 1% mortality (Fig. 2b; p < 0.001 
vs. control). No significant differences were observed in 
the larvicidal capacity of live vs. heat-inactivated yeast 
interfering RNA larvicides (Fig.  2a vs. b). Heat-inacti-
vated Sac1.1 and otk.16 yeast fed to A. aegypti larvae, in 
which the target sequences of these interfering RNAs are 
not conserved, did not induce larval death (Additional 
file 2; p = 0.66).
Dried inactivated yeast interfering RNA larvicide tablets 
induce significant larval death
Although agarose-coated yeast larvicides induced high 
mortality rates (Fig. 2), these formulations are sticky and 
non user-friendly. Also, the water in containers treated 
with the gel-coated yeast becomes cloudy, which may 
not be desired by prospective users. To circumvent these 
issues, dried tablets of inactivated yeast (Fig. 3a), which 
are comparable in appearance to yeast nutritional tab-
lets sold as human dietary supplements, were there-
fore prepared and evaluated. This formulation is easier 
to handle, does not cloud the water in treated contain-
ers, and is readily consumed by Anopheles larvae. Treat-
ment of 50 mL water containing 20 larvae with a 95 mg 
dried tablet of yeast interfering RNA larvicide Sac1.1 
induced 89 ± 1% larval mortality (Fig. 3b; p < 0.001 vs. 
control). Dried yeast interfering RNA larvicide otk.16 
induced 89 ± 1% larval mortality (Fig. 3b; p < 0.001 vs. 
Fig. 2 Yeast interfering RNA larvicides induce significant mortality. Significant larval death was observed in larvae fed with gel‑coated live (a) or 
heat‑inactivated (b) yeast engineered to express shRNA corresponding to the Sac1.1 and otk.16 siRNA target sequences (as compared to control 
yeast expressing shRNA corresponding to the control siRNA sequence). Data were compiled from replicate experiments, with 120 larvae evaluated 
per condition for live yeast and 180 larvae assessed per condition for inactive yeast (see “Methods” for details). Data were statistically assessed by 
ANOVA with Tukey’s multiple comparison test. No statistically significant differences were observed in the larvicidal capacity of live vs. heat‑inacti‑
vated gel‑coated yeast interfering RNA larvicides. ***p < 0.001 in comparison to control‑fed larvae; error bars denote SEMs
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control). Yeast expressing shRNA corresponding to the 
lrc.51 target sequence was also prepared, and these tab-
lets induced 100 ± 0% larval mortality (Fig. 3b; p < 0.001 
vs. control). These results demonstrated that dried inacti-
vated yeast interfering RNA larvicide tablets have highly 
significant larvicidal activity.
Yeast interfering RNA larvicide‑mediated silencing of Sac1, 
otk, or lrc disrupts neural synapses in the larval brain
In D. melanogaster, Sac1 encodes phosphatidylinositol 
phosphatase, which functions to dephosphorylate phos-
phatidylinositol 4-phosphate for generation of phosphati-
dylinositol and acts as an axon guidance regulator [31]. 
The D. melanogaster otk gene encodes a member of the 
Tyrosine protein kinase superfamily which functions as 
a neural cell adhesion molecule to regulate axon guid-
ance [32, 33]. The D. melanogaster CG6700 gene is an 
lrc ortholog and encodes a conserved C-terminal SAC3/
GANP domain-containing protein member of the dystro-
glycan–dystrophin complex [34–36]. CG6700 was listed 
in a catalog of genes likely to function in synapse assem-
bly and function [37], but its function in this capacity 
remained to be tested. Given the reported neural func-
tions of the Sac1, lrc, and otk Drosophila orthologs, the 
functions of these genes were assessed in the mosquito 
brain (Fig. 4). Detection (Fig. 4a2 vs. a1) and quantifica-
tion (Fig.  4a3) of Sac1 transcript levels in the L4 larval 
brain demonstrated that ingestion of yeast interfering 
larvicide Sac1.1 resulted in 85  ±  5% reduction of Sac1 
transcripts (p  <  0.001). Detection (Fig.  4b2 vs. b1) and 
quantification (Fig. 4b3) of L4 larval brain lrc transcripts 
showed that ingestion of yeast interfering RNA larvicide 
lrc.51 resulted in 88  ±  6% reduction of lrc transcripts. 
Likewise, detection (Fig.  4c2 vs. c1) and quantification 
(Fig.  4c3) of otk transcripts in the L4 larval brain indi-
cated that ingestion of yeast interfering RNA larvicide 
otk.16 resulted in 83 ± 5% reduction of otk transcripts.
Detection of Synapsin expression (with mAb 3C11 
[30]), a marker of active neural synapses in multiple 
arthropod species [10], was used to assess synaptic activ-
ity in the brains of animals fed with these yeast interfer-
ing RNA larvicides. Synapsin expression was severely 
reduced in the synaptic neuropiles of animals fed with 
yeast interfering RNA larvicides Sac1.1 (Fig.  5b1, b2 vs. 
control-fed animals in a1, a2), lrc.51 (Fig. 5c1, c2 vs. a1, 
a2), and otk.16 (Fig. 5d1, d2 vs. a1, a2). These severe neu-
ral phenotypes are likely to be primary causes of larval 
death in animals fed with yeast interfering RNA larvi-
cides targeting these genes.
Discussion
Numerous studies have demonstrated that target gene 
silencing through RNAi can promote insect death [6]. 
For example, Baum et  al. [38] engineered transgenic 
corn plants expressing dsRNA targeting the western 
corn rootworm Diabrotica virgifera virgifera. dsRNA 
insecticidal corn targeting this species was recently reg-
istered by the US Environmental Protection Agency [39], 
which deemed that this intervention meets the regula-
tory standards described in the Federal Insecticide, Fun-
gicide, and Rodenticide Act [40]. Likewise, Whyard et al. 
[41] showed that Tribolium castaneum, Acyrthosiphon 
Fig. 3 Dried inactivated yeast interfering RNA tablets induce significant larval death. Dried inactivated yeast interfering RNA larvicide tablets (a; 
penny shown for scale) were prepared and fed to 20 larvae. Significant larval death was observed in larvae fed with yeast expressing shRNA hairpins 
corresponding to the Sac1.1, lrc.51, and otk.16 target sequences as compared to larvae fed control yeast interfering RNA tablets (b). Data were com‑
piled from three biological replicate experiments (total n = 240 larvae/condition; see “Methods” for details) and analysed by ANOVA with Tukey’s 
multiple comparison test. ***p < 0.001 in comparison to control‑fed larvae; error bars denote SEMs
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Fig. 4 Confirmed silencing of the Sac1, lrc, and otk genes in the larval brain by dried inactivated yeast interfering RNA tablets. Significantly lower 
levels of Sac1 (a1–a3), lrc (b1–b3), and otk (c1–c3) transcripts were detected in the L4 brains of larvae fed with the Sac1.1 (a2), lrc.51 (b2), and 
otk.16 (c2) dried inactivated yeast interfering RNA larvicides vs. animals fed with control yeast (a1, b1, c1). For each probe, results from three 
biological replicate experiments were compiled (n = 85 Sac1.1‑treated brains, n = 80 lrc.51‑treated brains, and n = 80 otk.16‑treated brains; n = 40 
control‑treated brains/per experiment). Data were evaluated by t test (***p < 0.001 in comparison to control‑fed larvae). The brains are oriented dor‑
sal upward in this figure. LAL, larval antennal lobe; OF, olfactory foramen; OL, optic lobe; SOG, sub‑oesophageal ganglion; SuEG, supra‑oesophageal 
ganglion
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(See figure on previous page.) 
Fig. 5 Neural defects observed in larvae treated with yeast interfering RNA larvicides Sac1.1, lrc.51, and otk.16. L4 larval brains were labeled with 
mAb3C11 (white in a1–d1; red in a2–d2), which labels expression of Synapsin, a marker for the neuropil and synaptic active zones. TO‑PRO was 
used to counter‑stain nuclei in the brain (blue in a2–d2). The brains of larvae fed with yeast expressing shRNAs Sac1.1 (b1, b2), lrc.51 (c1, c2), and 
otk.16 (d1, d2) yeast interfering RNA tablets show loss of staining in the synaptic neuropil regions when compared with animals fed with control 
yeast (a1, a2). Three biological replicate experiments were performed. The data shown are representative of the results from 25 brains evaluated per 
condition. LAL, larval antennal lobe; OF, olfactory foramen; OL, optic lobe; SOG, sub‑oesophageal ganglion; SuEG, supra‑oesophageal ganglion
pisum, and Manduca sexta were killed when fed species-
specific dsRNA targeting vATPase. The sequence speci-
ficity of RNAi facilitated their design of dsRNAs that 
targeted specific chosen insects, but which did not kill 
non-target insects, including closely related insect spe-
cies [41]. Similarly, this study designed yeast interfering 
RNA larvicides with target sequences in Anopheles lar-
val lethal genes that are not perfectly conserved in other 
organisms (Additional file 1) and which failed to kill A. 
aegypti (Additional file  2). Of course, the ability of an 
siRNA to have off-target effects is complicated [42]. It is 
difficult to predict, on the basis of sequence information 
alone, whether these yeast interfering RNA larvicides 
could impact gene expression in non-target organisms 
[42], and it will be important to conduct more detailed 
toxicity studies on these larvicides. However, in general, 
interfering RNA pesticides are believed to be much safer 
than chemical pesticides [43]. MonSanto [43] concluded, 
in an extensive evaluation of RNA molecules prepared 
for the United States Environmental Protection Agency, 
that RNA based products are an important technology 
with great promise for pest mitigation applications while 
presenting an overwhelmingly desirable safety profile, 
particularly when compared to conventional pesticides. 
Moreover, although many had questioned whether 
interfering RNAs were sufficiently stable for field appli-
cations, dsRNA stability has actually been reported to 
be quite high [44, 45]. These and other studies suggest 
that RNAi can be exploited to control insect agricultural 
pests.
RNAi has been used extensively for functional analysis 
of mosquito genes [10–14]. However, RNAi has not yet 
emerged as a method for mosquito control. The results 
of this investigation, in which a number of larval lethal 
genes to be targeted and an effective delivery system for 
interfering RNAs targeting these genes were identified, 
suggest that the addition of RNAi pesticides to inte-
grated mosquito control programmes may be feasible 
and beneficial. Through the identification of multiple 
larval lethal genes and target sites in these genes, includ-
ing those described here and additional RNAi targets in 
the An. gambiae genome that have been discovered and 
tested, the authors hope to build an arsenal of interfer-
ing RNAs that can be used to combat resistance to tradi-
tional chemical pesticides. This arsenal can also be used 
to combat future resistance that might develop to any 
single interfering RNA pesticide.
The broad application of RNAi for pest control is 
dependent upon production of dsRNA in an economi-
cally feasible, scalable, and sustainable fashion. dsRNA 
manufacture has traditionally relied on expensive, car-
bon-intensive chemical synthesis, resulting in high costs 
[5, 6] and a perception that use of RNAi for mosquito 
control would be prohibitively expensive. Additionally, 
a perceived high operational cost and the complexity of 
Anopheles larviciding in general has deterred some mos-
quito control programmes from adopting LSM strategies 
for malaria vector control [3]. The use of ready-to-use 
yeast interfering RNA larvicide tablets, which are a user-
friendly economically feasible biorational alternative to 
conventional larvicides  may help to address these con-
cerns. While Pichia pastoris has been used for expres-
sion of recombinant DNA and dsRNA to target Aedes [46, 
47], in this investigation, we opted to use S. cerevisiae, for 
which many mutant strains and plasmid constructs exist. 
Interfering RNA was affordably propagated through cul-
tivation of the yeast. The first three Anopheles interfering 
RNA larvicides generated in S. cerevisiae, Sac1.1, lrc.51, 
and otk.16 (Figs. 2, 3), effectively killed mosquitoes, with 
lrc.51 inducing 100% larval mortality. As with bacteria 
[23], the larvicides retained full activity after the yeast was 
heat-killed (Fig.  2), which circumvents concerns for the 
introduction of live genetically modified organisms for 
mosquito control.
Saccharomyces cerevisiae has been cultivated world-
wide for thousands of years, and this technology can be 
adapted to resource-limited countries with constrained 
infrastructures. Moreover, dried yeast can be packaged 
and shipped in both active (live) or inactive (dead) forms, 
which will facilitate regional distribution. Yeast produc-
tion is readily scaled to industry-sized cultures, and so 
commercialization of this intervention is feasible. S. cer-
evisiae, which is non-toxic to humans, is already used 
globally in food and alcoholic beverage preparation. 
Dried inactive yeast is sold commercially as a dietary 
supplement and is available in tablet or flake formula-
tions. It is anticipated that heat-inactivated yeast interfer-
ing RNA, which demonstrated high larvicidal activities in 
this investigation, could be prepared in bulk and distrib-
uted in these ready-to-use dried formulations.
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Given the many benefits of the yeast system, the encour-
aging results reported in this study, as well as a recent study 
in the agricultural pest Drosophila suzukii [48], support the 
pursuit of proof-of-concept semi-field evaluation of yeast 
interfering RNA larvicides. To this end, semi-field trials 
with heat inactivated yeast interfering RNA larvicides are 
planned. This critical next phase of the project will facili-
tate evaluation of the efficacy, feasibility, and acceptance 
of introducing biorational yeast interfering RNA larvicides 
into integrated vector mosquito control programmes. Given 
that yeast, a strong odorant attractant for larvae, can act as 
a larval bait [10], it is likely that yeast interfering RNA pel-
lets could be used to treat volumes of water that are much 
larger than those used in the present investigation, and this 
will need to be assessed in the field. It would also be inter-
esting to test additional yeast formulations in the field. For 
example, it is possible that some species of Anopheles lar-
vae may more readily ingest yeast interfering RNA flakes 
that float at the water surface, and this could become critical 
in the field, where competing food sources are available to 
larvae. Finally, in addition to assessing the impacts of yeast 
interfering RNA larvicides on the densities of juvenile and 
adult mosquitoes in the field, it will be important to exam-
ine the best settings for the use of these larvicides, if they 
can be used for control of other malaria vector mosquitoes, 
and ultimately to demonstrate that the larvicides can effec-
tively reduce the number of malaria cases.
Conclusions
In summary, new vector control tools to address residual 
malaria transmission are vitally needed. The laboratory 
trials conducted in this investigation demonstrated that 
yeast expressing shRNA corresponding to An. gambiae 
larval lethal genes induce up to 100% larval mortality. 
These yeast interfering RNA larvicides retain larvicidal 
activity following drying and heat-inactivation of the 
yeast into ready-to-use tablet formulations. Dried inacti-
vated yeast interfering RNA larvicide tablets could some-
day be an effective, inexpensive, biorational addition to 
malaria mosquito control programmes and a valuable 
tool for combating residual malaria transmission.
Abbreviations
ANOVA: analysis of variance; BLAST: basic local alignment search tool; 
DDT: dichlorodiphenyltrichloroethane; dsRNA: double stranded RNA; EPA: 
Additional files
Additional file 1. Lack of siRNA larvicide target site conservation in non‐
target organisms. Summary of Blast search results.
Additional file 2. A lack of Sac1.1 and otk.16 yeast interfering larvicide 
activity in A. aegypti larvae. Graph depicting results from larvicide trials 
that demonstrated a lack of larvicidal activity for yeast interfering RNA 
larvicides Sac1.1 and otk.16 in A. aegypti larvae.
Environmental Protection Agency; L1: first instar; IRS: indoor residual spraying; 
ITNs: insecticide treated nets; lrc: leukocyte receptor complex member; otk: 
offtrack; RNAi: RNA interference; shRNA: short hairpin RNA; siRNA: small inter‑
fering RNA; Sac1: suppressor of actin; WHO: World Health Organization.
Authors’ contributions
KM acquired, analysed, and interpreted the yeast larvicide data and assisted 
with manuscript preparation. LH assisted with study design, acquired, and 
analysed the yeast larvicide data. LS performed and helped analyse the micro‑
injection screen and assisted with mosquito rearing. EIH and JSR performed 
and helped analyse the soaking screen and assisted with mosquito rearing. 
NDS performed and analysed the Aedes aegypti studies. YC prepared the 
yeast used in these studies and assisted with data analysis. KE, DWS and NW 
assisted with study design, data analysis, and interpretation. MDS prepared the 
manuscript, conceived of the study, designed experiments, and assisted with 
cloning, data analysis and interpretation. All authors read and approved the 
final manuscript.
Author details
1 Dept. of Medical and Molecular Genetics, Indiana University School of Medi‑
cine, 1234 Notre Dame Avenue, South Bend, IN 46530, USA. 2 The University 
of Notre Dame, Eck Institute for Global Health, Notre Dame, IN 46556, USA. 
3 Dept. of Biological Sciences, The University of Notre Dame, Notre Dame, 
IN 46556, USA. 4 Dept. of Civil and Environmental Engineering and Earth 
Sciences, The University of Notre Dame, Notre Dame, IN 46556, USA. 5 Dept. 
of Medicine, Indiana University School of Medicine, 1234 Notre Dame Avenue, 
South Bend, IN 46530, USA. 
Acknowledgements
Thanks to Nicole Achee, John Grieco, Neil Lobo, and our colleagues in the Eck 
Institute for Global Health for useful discussions.
Competing interests
MDS, KKE, NW, and DWS have filed a patent application.
Availability of data and materials
All data generated or analysed during this study are included in this published 
article.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Not applicable.
Funding
This work was funded by Bill and Melinda Gates Grand Challenges and 
Explorations Grant OPP ID # OPP1129038 and an Indiana University School of 
Medicine Ralph W. and Grace M. Showalter Research Trust Fund award to MDS. 
The funding sources were not involved in study design, data collection and 
interpretation, or the decision to submit the work for publication.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub‑
lished maps and institutional affiliations.
Received: 11 July 2017   Accepted: 8 November 2017
References
 1. WHO. World malaria report 2016. Geneva: World Health Organization; 
2016.
 2. WHO. Larval source management: a supplementary measure for malaria 
vector control: an operational manual. Geneva: World Health Organiza‑
tion; 2013.
 3. Fillinger U, Lindsay SW. Larval source management for malaria control in 
Africa: myths and reality. Malar J. 2011;10:353.
Page 11 of 12Mysore et al. Malar J  (2017) 16:461 
 4. Afrane YA, Mweresa NG, Wanjala CL, Gilbreath Iii TM, Zhou G, Lee MC, 
Githeko AK, Yan G. Evaluation of long‑lasting microbial larvicide for 
malaria vector control in Kenya. Malar J. 2016;15:577.
 5. Yu N, Christiaens O, Liu J, Niu J, Cappelle K, Caccia S, Huvenne H, Smag‑
ghe G. Delivery of dsRNA for RNAi in insects: an overview and future 
directions. Insect Sci. 2013;20:4–14.
 6. Zhang H, Li HC, Miao XX. Feasibility, limitation and possible solutions of 
RNAi‑based technology for insect pest control. Insect Sci. 2013;20:15–30.
 7. EPA. Pesticide product with new active ingredients dsRNA transcipt com‑
prising a DvSnf7 inverted repeat sequence derived from Diabrotica virgif-
era virgifera and Bt Cry3Bb1 protein and the genetic material necessary 
for their production (vector PV‑ZMIR10871) in MON 87411 Corn (OECD 
Unique Identifier MON‑87411‑9)—FIFRA. 2015. https://www.noticeand‑
comment.com/Final‑Regulatory‑Decision‑for‑New‑Active‑Ingredients‑
Double‑stranded‑Ribonucleic‑Acid‑Transcript‑Comprising‑fn‑316831.
aspx. Accessed Nov 2015.
 8. Qiu S, Adema CM, Lane T. A computational study of off‑target effects of 
RNA interference. Nucleic Acids Res. 2005;33:1834–47.
 9. Moffat J, Reiling JH, Sabatini DM. Off‑target effects associated with 
long dsRNAs in Drosophila RNAi screens. Trends Pharmacol Sci. 
2007;28:149–51.
 10. Mysore K, Flannery EM, Tomchaney M, Severson DW, Duman‑Scheel 
M. Disruption of Aedes aegypti olfactory system development through 
chitosan/siRNA nanoparticle targeting of semaphorin‑1a. PLoS Negl Trop 
Dis. 2013;7(5):e2215.
 11. Mysore K, Andrews E, Li P, Duman‑Scheel M. Chitosan/siRNA nanoparticle 
targeting demonstrates a requirement for single‑minded during larval 
and pupal olfactory system development of the vector mosquito Aedes 
aegypti. BMC Dev Biol. 2014;14:9.
 12. Mysore K, Flannery E, Leming MT, Tomchaney M, Shi L, Sun L, O’Tousa 
JE, et al. Role of semaphorin‑1a in the developing visual system of the 
disease vector mosquito Aedes aegypti. Dev Dyn. 2014;243:1457–69.
 13. Mysore K, Sun L, Tomchaney M, Sullivan G, Adams H, Piscoya AS, et al. 
siRNA‑mediated silencing of doublesex during female development 
of the dengue vector mosquito Aedes aegypti. PLoS Negl Trop Dis. 
2015;9:e0004213.
 14. Tomchaney M, Mysore K, Sun L, Li P, Emrich SJ, Severson DW, et al. Exami‑
nation of the genetic basis for sexual dimorphism in the Aedes aegypti 
(dengue vector mosquito) pupal brain. Biol Sex Differ. 2014;5:10.
 15. Clemons A, Mori A, Haugen M, Severson DW, Duman‑Scheel M. Culturing 
and egg collection of Aedes aegypti. Cold Spring Harb Protoc. 2010;pdb 
prot5507.
 16. St Pierre SE, Ponting L, Stefancsik R, McQuilton P, FlyBase Consortium. 
FlyBase 102‑advanced approaches to interrogating FlyBase. Nucleic Acids 
Res. 2014;42:D780–8.
 17. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment 
search tool. J Mol Biol. 1990;215:403–10.
 18. Blitzer EJ, Vyazunova I, Lan Q. Functional analysis of AeSCP‑2 using gene 
expression knockdown in the yellow fever mosquito, Aedes aegypti. Insect 
Mol Biol. 2005;14:301–7.
 19. Clemons A, Haugen M, Le C, Mori A, Tomchaney M, Severson DW, 
Duman‑Scheel M. siRNA‑mediated gene targeting in Aedes aegypti 
embryos reveals that frazzled regulates vector mosquito CNS develop‑
ment. PLoS ONE. 2011;6:e16730.
 20. Singh AD, Wong S, Ryan CP, Whyard S. Oral delivery of double‑stranded 
RNA in larvae of the yellow fever mosquito, Aedes aegypti: implications for 
pest mosquito control. J Insect Sci. 2013;13:69.
 21. WHO. Guidelines for laboratory and field testing of mosquito larvicides. 
Geneva: World Health Organization; 2005.
 22. Fisher RA. Statistical methods for research workers. Edinburgh: Oliver and 
Boyd; 1925.
 23. Whyard S, Erdelyan CN, Partridge AL, Singh AD, Beebe NW, Capina 
R. Silencing the buzz: a new approach to population suppression of 
mosquitoes by feeding larvae double‑stranded RNAs. Parasit Vectors. 
2015;8:96.
 24. Mumberg D, Muller R, Funk M. Yeast vectors for the controlled expres‑
sion of heterologous proteins in different genetic backgrounds. Gene. 
1995;156:119–22.
 25. Winzeler EA, Shoemaker DD, Astromoff A, Liang H, Anderson K, Andre 
B, et al. Functional characterization of the S. cerevisiae genome by gene 
deletion and parallel analysis. Science. 1999;285:901–6.
 26. Patel NH. In situ hybridization to whole mount Drosophila embryos. In: 
Krieg PA, editor. A laboratory guide to RNA: isolation, analysis, and synthe‑
sis. New York: Wiley‑Liss; 1996. p. 357–70.
 27. Haugen M, Tomchaney M, Kast K, Flannery E, Clemons A, Jacowski C, et al. 
Whole‑mount in situ hybridization for analysis of gene expression during 
Aedes aegypti development. Cold Spring Harb Protoc. 2010(10). https://
doi.org/10.1101/pdb.prot5509.
 28. Clemons A, Flannery E, Kast K, Severson D, Duman‑Scheel M. Immunohis‑
tochemical analysis of protein expression during Aedes aegypti develop‑
ment. Cold Spring Harb Protoc. 2010(10). https://doi.org/10.1101/pdb.
prot5510
 29. Mysore K, Flister S, Muller P, Rodrigues V, Reichert H. Brain development 
in the yellow fever mosquito Aedes aegypti: a comparative immunocy‑
tochemical analysis using cross‑reacting antibodies from Drosophila 
melanogaster. Dev Genes Evol. 2011;221:281–96.
 30. Klagges BR, Heimbeck G, Godenschwege TA, Hofbauer A, Pflugfelder GO, 
Reifegerste R, et al. Invertebrate synapsins: a single gene codes for several 
isoforms in Drosophila. J Neurosci. 1996;16:3154–65.
 31. Lee S, Kim S, Nahm M, Kim E, Kim TI, Yoon JH, Lee S. The phosphoinositide 
phosphatase Sac1 is required for midline axon guidance. Mol Cells. 
2011;32:477–82.
 32. Pulido D, Campuzano S, Koda T, Modolell J, Barbacid M. Dtrk, a Drosophila 
gene related to the trk family of neurotrophin receptors, encodes a novel 
class of neural cell adhesion molecule. EMBO J. 1992;11:391–404.
 33. Winberg ML, Tamagnone L, Bai J, Comoglio PM, Montell D, Goodman 
CS. The transmembrane protein Off‑track associates with Plexins and 
functions downstream of Semaphorin signaling during axon guidance. 
Neuron. 2001;32:53–62.
 34. Dietzl G, Chen D, Schnorrer F, Su KC, Barinova Y, Fellner M, et al. A 
genome‑wide transgenic RNAi library for conditional gene inactivation in 
Drosophila. Nature. 2007;448:151–6.
 35. Jankovics F, Henn L, Bujna A, Vilmos P, Kiss N, Erdelyi M. A functional 
genomic screen combined with time‑lapse microscopy uncovers a novel 
set of genes involved in dorsal closure of Drosophila embryos. PLoS ONE. 
2011;6:e22229.
 36. Kucherenko MM, Pantoja M, Yatsenko AS, Shcherbata HR, Fischer KA, 
Maksymiv DV, et al. Genetic modifier screens reveal new components 
that interact with the Drosophila dystroglycan–dystrophin complex. PLoS 
ONE. 2008;3:e2418.
 37. Pazos Obregon F, Papalardo C, Castro S, Guerberoff G, Cantera R. Putative 
synaptic genes defined from a Drosophila whole body developmen‑
tal transcriptome by a machine learning approach. BMC Genomics. 
2015;16:694.
 38. Baum JA, Bogaert T, Clinton W, Heck GR, Feldmann P, Ilagan O, et al. 
Control of coleopteran insect pests through RNA interference. Nat Bio‑
technol. 2007;25:1322–6.
 39. EPA. Pesticide product with new active ingredients dsRNA transcript 
comprising a DvSnf7 inverted repeat sequence derived from Diabrotica 
virgifera virgifera and Bt Cry3Bb1 protein and the genetic material 
necessary for their production (vector PV‑ZMIR10871) in MON 87411 
Corn (OECD Unique Identifier MON‑87411‑9)—FIFRA. 2015. https://
www.noticeandcomment.com/EPA‑HQ‑OPP‑2014‑0293‑fdt‑52976.aspx. 
Accessed July 2017.
 40. FIRFA. Summary of the Federal insecticide, fungicide, and rodenticide act. 
2015. http://www.epa.gov/laws‑regulations/summary‑federal‑insecti‑
cide‑fungicide‑and‑rodenticide‑act. Accessed Nov 2015.
 41. Whyard S, Singh AD, Wong S. Ingested double‑stranded RNAs can act as 
species‑specific insecticides. Insect Biochem Mol Biol. 2009;39:824–32.
 42. Jackson AL, Linsley PS. Recognizing and avoiding siRNA off‑target effects 
for target identification and therapeutic application. Nat Rev Drug Discov. 
2010;9:57–67.
 43. MonSanto. Docket ID: EPA‑HQ‑OPP‑2013‑0485. 2014. https://www.
apsnet.org/members/outreach/ppb/Documents/Monsantopostedwrit‑
tencommentJan2014.pdf. Accessed June 2015.
 44. Li H, Guan R, Guo H, Miao X. New insights into an RNAi approach for plant 
defence against piercing‑sucking and stem‑borer insect pests. Plant Cell 
Environ. 2015;38:2277–85.
 45. San Miguel K, Scott JG. The next generation of insecticides: 
dsRNA is stable as a foliar‑applied insecticide. Pest Manag Sci. 
2016;72:801–9.
Page 12 of 12Mysore et al. Malar J  (2017) 16:461 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 46. Borovsky D, Nauwelaers S, Van Mileghem A, Meyvis Y, Laeremans A, Theu‑
nis C, et al. Control of mosquito larvae with TMOF and 60 kDa Cry4Aa 
expressed in Pichia pastoris. Pestycydy/Pesticides. 2011;1:5–15.
 47. Van Ekert E, Powell CA, Shatters RG Jr, Borovsky D. Control of larval and 
egg development in Aedes aegypti with RNA interference against juvenile 
hormone acid methyl transferase. J Insect Physiol. 2014;70:143–50.
 48. Murphy KA, Tabuloc CA, Cervantes KR, Chiu JC. Ingestion of genetically 
modified yeast symbiont reduces fitness of an insect pest via RNA inter‑
ference. Sci Rep. 2016;6:22587.
